NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP)

163 filings reported holding NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) as of Q4 2021.
NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) has 128 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 39.1M shares of 264M outstanding shares and own 14.78% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (7.35M shares), HHLR ADVISORS, LTD. (7.18M shares), BlackRock Inc. (2.46M shares), Cederberg Capital Ltd (2.32M shares), MORGAN STANLEY (1.46M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.4M shares), Zeal Asset Management Ltd (1.38M shares), Octagon Capital Advisors LP (1.05M shares), PICTET ASSET MANAGEMENT SA (1.02M shares), and VANGUARD GROUP INC (975K shares).
This table shows the top 128 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.